Health Care [ 3/12 ] | Biotechnology [ 9/75 ]
NASDAQ | Common Stock
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens.
The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 26, 26 | 0.00 Increased by +100.00% | -0.63 Increased by +100.00% |
| Nov 6, 25 | -0.49 Increased by +16.95% | -0.59 Increased by +16.95% |
| Aug 7, 25 | -0.54 Increased by +11.48% | -0.64 Increased by +15.62% |
| May 7, 25 | -0.55 Increased by +15.38% | -0.53 Decreased by -3.77% |
| Feb 26, 25 | -0.55 Increased by +16.67% | -0.76 Increased by +27.63% |
| Nov 1, 24 | -0.59 Increased by +9.23% | -0.77 Increased by +23.38% |
| Aug 12, 24 | -0.61 Decreased by -22.00% | -0.76 Increased by +19.74% |
| May 9, 24 | -0.65 Increased by +15.58% | -0.72 Increased by +9.72% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 100.00 K Decreased by -90.00% | -2.95 M Increased by +35.92% | Decreased by -2.95 K% Decreased by -540.78% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -4.25 M Increased by +13.81% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 70.00 K Increased by +N/A% | -4.66 M Increased by +7.63% | Decreased by -6.66 K% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -4.72 M Increased by +12.53% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 1.00 M Increased by +N/A% | -4.61 M Increased by +14.07% | Decreased by -461.00% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -4.93 M Increased by +6.29% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -5.04 M Decreased by -25.25% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -5.40 M Increased by +12.70% | Decreased by N/A% Decreased by N/A% |